GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (BUD:BAYER) » Definitions » Cyclically Adjusted Price-to-FCF

Bayer AG (BUD:BAYER) Cyclically Adjusted Price-to-FCF : 5.03 (As of May. 25, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Bayer AG Cyclically Adjusted Price-to-FCF?

As of today (2024-05-25), Bayer AG's current share price is Ft10578.00. Bayer AG's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was Ft2,103.83. Bayer AG's Cyclically Adjusted Price-to-FCF for today is 5.03.

The historical rank and industry rank for Bayer AG's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

BUD:BAYER' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 4.78   Med: 13.84   Max: 33.49
Current: 5.2

During the past years, Bayer AG's highest Cyclically Adjusted Price-to-FCF was 33.49. The lowest was 4.78. And the median was 13.84.

BUD:BAYER's Cyclically Adjusted Price-to-FCF is ranked better than
95.85% of 313 companies
in the Drug Manufacturers industry
Industry Median: 33.08 vs BUD:BAYER: 5.20

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Bayer AG's adjusted free cash flow per share data for the three months ended in Mar. 2024 was Ft-1,016.944. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is Ft2,103.83 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bayer AG Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Bayer AG's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Cyclically Adjusted Price-to-FCF Chart

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.47 9.52 9.29 8.77 6.12

Bayer AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.19 9.92 8.81 6.12 5.35

Competitive Comparison of Bayer AG's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - General subindustry, Bayer AG's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bayer AG's Cyclically Adjusted Price-to-FCF falls into.



Bayer AG Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Bayer AG's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=10578.00/2103.83
=5.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bayer AG's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1016.944/125.0381*125.0381
=-1,016.944

Current CPI (Mar. 2024) = 125.0381.

Bayer AG Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 622.299 99.543 781.686
201409 701.519 99.823 878.726
201412 682.656 99.543 857.502
201503 176.361 99.717 221.145
201506 649.044 100.417 808.185
201509 806.184 100.417 1,003.854
201512 447.829 99.717 561.548
201603 457.237 100.017 571.625
201606 670.132 100.717 831.957
201609 1,151.833 101.017 1,425.733
201612 774.964 101.217 957.350
201703 185.124 101.417 228.242
201706 825.585 102.117 1,010.895
201709 1,026.478 102.717 1,249.537
201712 639.241 102.617 778.910
201803 152.336 102.917 185.079
201806 804.487 104.017 967.065
201809 586.736 104.718 700.593
201812 756.630 104.217 907.791
201903 279.189 104.217 334.966
201906 465.381 105.718 550.432
201909 616.398 106.018 726.985
201912 872.168 105.818 1,030.587
202003 -246.901 105.718 -292.024
202006 742.303 106.618 870.550
202009 601.934 105.818 711.268
202012 -62.258 105.518 -73.776
202103 -1,327.459 107.518 -1,543.770
202106 653.055 108.486 752.695
202109 916.678 109.435 1,047.380
202112 776.175 110.384 879.221
202203 -426.681 113.968 -468.126
202206 592.025 115.760 639.473
202209 687.964 118.818 723.980
202212 663.144 119.345 694.778
202303 -1,549.627 122.402 -1,582.995
202306 -47.636 123.140 -48.370
202309 728.100 124.195 733.045
202312 1,812.200 123.773 1,830.724
202403 -1,016.944 125.038 -1,016.944

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bayer AG  (BUD:BAYER) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Bayer AG Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Bayer AG's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG (BUD:BAYER) Business Description

Industry
Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Bayer AG (BUD:BAYER) Headlines

No Headlines